{"id":"https://openalex.org/W7225466478","doi":"https://doi.org/10.5281/zenodo.24041300","title":"ASME V&V 40 In Silico Validation of Berberine and Silymarin Cardiometabolic Synergy: P-Glycoprotein Efflux Modulation, 2.3-Fold Bioavailability Enhancement, and Replication of Landmark Human Clinical Trials","display_name":"ASME V&V 40 In Silico Validation of Berberine and Silymarin Cardiometabolic Synergy: P-Glycoprotein Efflux Modulation, 2.3-Fold Bioavailability Enhancement, and Replication of Landmark Human Clinical Trials","publication_year":2026,"publication_date":"2026-11-07","ids":{"openalex":"https://openalex.org/W7225466478","doi":"https://doi.org/10.5281/zenodo.24041300"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.24041300","doi":"https://doi.org/10.5281/zenodo.24041300","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24041300","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.24041300","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5152335614","display_name":"Harri Lanzett","orcid":"https://orcid.org/0000-0002-9574-3805","observed_orcids":["https://orcid.org/0000-0002-9574-3805"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Lanzett, Harri","raw_affiliation_strings":["Sampo AI Research Laboratory & The Hygieia Workbench"],"raw_orcid":"https://orcid.org/0009-0008-5820-634X","affiliations":[{"raw_affiliation_string":"Sampo AI Research Laboratory & The Hygieia Workbench","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5152335614"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.5826,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.81226415,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12059","display_name":"Berberine and alkaloids research","score":0.8086000084877014,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12059","display_name":"Berberine and alkaloids research","score":0.8086000084877014,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.11509999632835388,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.012000000104308128,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/berberine","display_name":"berberine","score":1.0},{"id":"https://openalex.org/keywords/silymarin","display_name":"silymarin","score":1.0},{"id":"https://openalex.org/keywords/p-glycoprotein-inhibition","display_name":"P-glycoprotein inhibition","score":0.8939999938011169},{"id":"https://openalex.org/keywords/oral-bioavailability-enhancement","display_name":"oral bioavailability enhancement","score":0.8510000109672546},{"id":"https://openalex.org/keywords/pharmacokinetic-simulation","display_name":"pharmacokinetic simulation","score":0.6370000243186951},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.5370000004768372}],"concepts":[{"id":"https://openalex.org/C2780116568","wikidata":"https://www.wikidata.org/wiki/Q176525","display_name":"Berberine","level":2,"score":0.948199987411499},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.8679999709129333},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7263000011444092},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.7049999833106995},{"id":"https://openalex.org/C2775905019","wikidata":"https://www.wikidata.org/wiki/Q192572","display_name":"In silico","level":3,"score":0.6122000217437744},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5975000262260437},{"id":"https://openalex.org/C200082930","wikidata":"https://www.wikidata.org/wiki/Q22327148","display_name":"Efflux","level":2,"score":0.5494999885559082},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4918000102043152},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.3935000002384186},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.3711000084877014},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3625999987125397},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33340001106262207},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.29319998621940613},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.2563000023365021}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.24041300","doi":"https://doi.org/10.5281/zenodo.24041300","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24041300","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"},{"id":"doi:10.5281/zenodo.24041301","doi":"https://doi.org/10.5281/zenodo.24041301","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24041301","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"doi:10.5281/zenodo.24041300","doi":"https://doi.org/10.5281/zenodo.24041300","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.24041300","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"},"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4414299596","https://openalex.org/W7225453486","https://openalex.org/W7160926914","https://openalex.org/W4381469935","https://openalex.org/W2909693419","https://openalex.org/W1972661330","https://openalex.org/W3086056825","https://openalex.org/W4312402367","https://openalex.org/W2569832747","https://openalex.org/W2896052293"],"abstract_inverted_index":{"Prospective":[0],"in":[1],"silico":[2],"replication":[3],"of":[4,149],"landmark":[5],"human":[6,126],"randomized":[7],"controlled":[8],"trials":[9,129],"(Di":[10],"Pierro":[11],"et":[12,18],"al.,":[13,19],"2012,":[14],"2013,":[15],"2015;":[16],"Guarino":[17],"2017)":[20],"evaluating":[21],"the":[22,33,50,170,181],"cardiometabolic":[23],"synergy":[24],"and":[25,30,49,76,116,139],"bioavailability":[26,83],"enhancement":[27],"between":[28],"berberine":[29,108,173],"silymarin":[31,100,177],"under":[32],"ASME":[34],"V&V":[35],"40":[36],"verification":[37],"standard.":[38],"Utilizing":[39],"a":[40,145],"frozen":[41],"European":[42],"adult":[43],"male":[44],"reference":[45],"physiology":[46],"(73":[47],"kg)":[48],"implicit":[51],"stiff":[52],"Radau":[53],"IIA":[54],"differential":[55],"ODE":[56],"solver,":[57],"Hygieia":[58],"modeled":[59],"60-day":[60],"repeated":[61],"daily":[62],"dosing":[63],"across":[64],"four":[65],"arms:":[66],"Placebo,":[67],"Berberine":[68,78],"500":[69,171],"mg":[70,74,172,176],"alone,":[71,75],"Silymarin":[72],"105":[73,175],"Co-administration.":[77],"alone":[79],"exhibited":[80],"low":[81],"oral":[82],"due":[84],"to":[85,137,142],"enterocyte":[86],"apical":[87],"P-glycoprotein":[88],"(P-gp":[89],"/":[90],"ABCB1)":[91],"extrusion":[92],"(hepatic":[93],"tissue":[94,110],"exposure":[95,111],"12.515":[96],"ug/mL).":[97],"Co-administration":[98],"with":[99],"(which":[101],"inhibits":[102],"P-gp":[103],"efflux":[104],"by":[105,112,120],"72%)":[106],"elevated":[107],"hepatic":[109,133],"2.32-fold":[113],"(29.092":[114],"ug/mL)":[115],"free":[117],"plasma":[118],"Cmax":[119],"2.13-fold":[121],"(10.446":[122],"ug/mL),":[123],"perfectly":[124],"replicating":[125],"clinical":[127,178,183],"pharmacokinetic":[128],"(2.5\u20133.8x":[130],"enhancement).":[131],"Sub-chronic":[132],"Nrf2":[134],"induction":[135],"increased":[136],"+609.7%":[138],"NF-kB":[140],"suppression":[141],"-66.6%,":[143],"yielding":[144],"Chou-Talalay":[146],"Combination":[147],"Index":[148],"CI":[150,156],"=":[151,161],"0.0839":[152],"(Very":[153],"Strong":[154],"Synergism,":[155],"<":[157],"0.30;":[158],"Fitness":[159],"J":[160],"254.04).":[162],"An":[163],"autonomous":[164],"20-point":[165],"combinatorial":[166],"response":[167],"surface":[168],"validates":[169],":":[174],"formulation":[179],"as":[180],"optimal":[182],"sweet":[184],"spot.":[185]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2026-11-08T00:00:00"}